University of Iowa, Hospitals and Clinics
Iowa City, Iowa 55242
55 studies enrolling now · 702 studies all time
What they study most
90-day Postoperative Surgical Site Infections, Superficial and Deep, AAA, AAA - Abdominal Aortic Aneurysm, ACL Tear, ALS, Acceptance and Commitment Therapy, Acoustic Schwannoma, Acute Coronary Syndrome, Acute Ischemic Stroke, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Studies at this site
- A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread — Recruiting now
- A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A — Recruiting now
- A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH) — Recruiting now
- A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies — Recruiting now
- A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A — Recruiting now
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure — Recruiting now
- A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
- Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants — Recruiting now
- Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 — Recruiting now
- Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration — Recruiting now
- A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment — Recruiting now
- Onyx™ Liquid Embolic IDE Clinical Study — Recruiting now
- A Study of 177Lu-FAP-2286 in Advanced Solid Tumors — Recruiting now
- A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis — Recruiting now
- Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT — Recruiting now
- Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis — Recruiting now
- Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer — Recruiting now
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
- The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs). — Recruiting now
- Paced Heart Rate Acceleration for Cardiac Conditioning — Recruiting now
- TSC Biosample Repository and Natural History Database — Recruiting now
- Carbon Dioxide (CO2) Chemosensitivity and SUDEP — Recruiting now
- NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study — Recruiting now
- BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer — Recruiting now
- Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma — Recruiting now
- Hyperbaric Oxygen Brain Injury Treatment Trial — Recruiting now
- Two Dose Levels of Privigen in Pediatric CIDP — Recruiting now
- REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE — Recruiting now
- Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
- Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm — Recruiting now
- MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer — Recruiting now
- Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer — Recruiting now
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation — Recruiting now
- Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer — Recruiting now
- Lurbinectedin in FET-Fused Tumors — Recruiting now
- Early Angiotensin II in the Emergency Department — Recruiting now
- Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis) — Recruiting now
- Behavioral Economic & Staffing Strategies in the ICU — Recruiting now
- The Effects of the CF Carrier State on the Kidneys and Pancreas — Recruiting now
- Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity — Recruiting now
- Diabetic Foot Ulcer Imaging- Study 2 — Recruiting now
- Post-Filter Hematocrit — Recruiting now
- Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients — Recruiting now
- A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients — Recruiting now
- A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC — Recruiting now
- Limited-duration Teclistamab — Recruiting now
- Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery — Recruiting now
- JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization — Recruiting now